Radiation Therapy in Treating Patients With Aggressive Fibromatoses

Status Completed

Clinical Trial Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who have aggressive fibromatoses.

Clinical Trial Description

OBJECTIVES:

- Determine the efficacy of moderate-dose radiotherapy, in terms of local control, in patients with aggressive fibromatoses.

- Determine the acute and late side-effects of this regimen in these patients.

OUTLINE: This is a multicenter study.

Patients receive radiotherapy 5 days a week for 5.5 weeks for a total of 56 Gy in 28 fractions.

Patients are followed every 3 months for 2 years and then every 6 months thereafter.

PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study within 3 years. ;

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Desmoid Tumor

Clinical Trial Details

NCT number	NCT00030680
Study type	Interventional
Source	European Organisation for Research and Treatment of Cancer - EORTC
Contact
Status	Completed
Phase	Phase 2
Start date	November 2001
Completion date	March 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05561036` - A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor	Phase 3
Completed	`NCT00287846` - Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis	Phase 1/Phase 2
Recruiting	`NCT06258421` - Burden of Disease and Living Situation in Desmoid Patients
Recruiting	`NCT06081400` - Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting	N/A
Active, not recruiting	`NCT04871282` - A Study of AL102 in Patients With Progressing Desmoid Tumors	Phase 2/Phase 3
Recruiting	`NCT01567046` - Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas	N/A
Completed	`NCT01137916` - Study to Evaluate Imatinib in Desmoid Tumors	Phase 2
Completed	`NCT00002595` - Toremifene in Treating Patients With Desmoid Tumors	Phase 2
Completed	`NCT03459469` - Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059	Phase 1
Completed	`NCT06195085` - CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Completed	`NCT01286662` - A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome	N/A
Completed	`NCT01265030` - A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis	Phase 1/Phase 2
Completed	`NCT00068419` - Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor	Phase 2
Completed	`NCT04289077` - Quality of Life of Patients With Desmoid-type Fibromatosis
Completed	`NCT03190174` - Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers	Phase 1/Phase 2
Completed	`NCT00003019` - Vinblastine and Methotrexate in Treating Children With Desmoid Tumors	Phase 2
Recruiting	`NCT05949099` - Study of Cryoablation and Nirogacestat for Desmoid Tumor	Phase 2
Active, not recruiting	`NCT02076906` - MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors	Phase 1
Completed	`NCT00474994` - Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas	Phase 2
Active, not recruiting	`NCT03785964` - Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)	Phase 3